Companies: Central Nervous System/Neurological/Spinal Cord Injury & Europe

Latest: Watch here for details of new products and services.

About Us: Pharmalicensing - Partnering solutions for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Deal Negotiation; PL Intelligence; Reports; Comparison
PL Intelligence: Overview; Industry news; Deals review; Press releases; Articles
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs
Contact Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd

Displaying 1..3 of 3 - per page
Order by

GW Pharmaceuticals develops a range of medicines based on cannabinoids and other controlled drugs More

Fully integrated global CNS pharmaceutical company More

Based in Heidelberg, Germany, BIOPHARM is a biotechnology firm, providing analytical and bioanalytical services More

Displaying 1..3 of 3 - per page
Order by

Therapeutic target: Central Nervous System del; Neurological del; Spinal cord injury del
Geographic location: Europe del

Industry sector: Academic/Research; Animal health; Biotechnology; Diagnostic; Drug delivery; Drug discovery; Medical device; Non-profit org./Government; Pharmaceutical; Research tools; Service
Geographic location: Albania; Andorra; Austria; Belgium; Belorussia; Bosnia-Herzegovina; Bulgaria; Croatia; Cyprus; Czech Republic; Denmark; Estonia; Finland; France; Germany; Greece; Greenland; Hungary; Iceland; Ireland; Italy; Latvia; Liechtenstein; Lithuania; Luxembourg; Macedonia; Malta; Netherlands; Norway; Poland; Portugal; Romania; Russia; San Marino; Slovakia; Slovenia; Spain; Sweden; Switzerland; Turkey; Ukraine; United Kingdom; Yugoslavia

Clients in focus...

Get the Flash Player to see this rotator.

Press releases: Pharmalicensing current industry press releases.